Endocrine oncology

Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study

Endocr PractPublished Cross-sectional study

Authors' conclusion

Despite the absence of a longitudinal design and internal control group, this study emphasizes the importance of systematically assessing HRQOL in DTC/PDTC patients with SIR and highlights the interplay between psychosocial factors and functional status in shaping patient-reported outcomes.

Study context

Population
Adults with cytologically or histologically confirmed DTC/PDTC and structural incomplete response (SIR)
Participants
148 adults
Outcome
Determinants of HRQOL (EORTC QLQ-C30, QLQ-THY34, Hospital Anxiety and Depression Scale)
Methodological detailsprospective, multicenter
  • Prospective
  • Multicenter

Main finding

As reported in the abstract

Determinants of HRQOL
  • SIR patients reported significantly reduced health-related quality of life (HRQOL) vs disease-free survivors, particularly fatigue, sleep disturbance, concern for others, exhaustion and joint pain
  • Neither disease management strategy (active surveillance vs tyrosine kinase inhibitor or other treatments) nor disease status (stable vs progressive) significantly predicted overall HRQOL
  • Lower physical functioning, female gender and higher emotional distress independently associated with poorer HRQOL
  • Gender-related differences emerged only among patients with preserved physical functioning

Observational data: associations, not effects.

Original publication

Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study. Endocr Pract. Published 2 April 2026. doi:10.1016/j.eprac.2026.03.090

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.